Genome-wide somatic mutation profiles of tumours can now be assessed efficiently and promise to move precision medicine forward. Statistical analysis of mutation profiles is however challenging due to the low frequency of most mutations, the varying mutation rates across tumours , and the presence of a majority of passenger events that hide the contribution of driver events. Here we propose a method, NetNorM, to represent whole-exome somatic mutation data in a form that enhances cancer-relevant information using a gene network as background knowledge. We evaluate its relevance for two tasks: survival prediction and unsupervised patient stratification. Using data from 8 cancer types from The Cancer Genome Atlas (TCGA), we show that it improv...
Disease progression in cancer can vary substantially between patients. Yet, patients often receive t...
<div><p>Development of high-throughput monitoring technologies enables interrogation of cancer sampl...
The Cancer Genome Atlas (TCGA) cancer genomics dataset includes over 10,000 tumor-normal exome pairs...
Genome-wide somatic mutation profiles of tumours can now be assessed efficiently and promise to move...
Many forms of cancer have multiple subtypes with different causes and clinical outcomes. Somatic tum...
<div><p>The stratification of cancer into subtypes that are significantly associated with clinical o...
The stratification of cancer into subtypes that are significantly associated with clinical outcomes ...
Large-scale cancer genomics projects are providing a wealth of somatic mutation data from a large nu...
A major goal of cancer sequencing projects is to identify genetic alterations that determine clinica...
BACKGROUND: Cancers are complex diseases with heterogeneous genetic causes and clinical outcomes. It...
Genome-wide measurements of genomic state offer unprecedented opportunities for biological discovery...
A major challenge for distinguishing cancer-causing driver mutations from inconsequential passenger ...
A central goal in cancer genomics is to identify the somatic alterations that underpin tumor initiat...
Next-generation sequencing technologies allow to measure somatic mutations in a large number of pati...
The post-genomic era has resulted in the accumulation of high-throughput cancer data from a vast arr...
Disease progression in cancer can vary substantially between patients. Yet, patients often receive t...
<div><p>Development of high-throughput monitoring technologies enables interrogation of cancer sampl...
The Cancer Genome Atlas (TCGA) cancer genomics dataset includes over 10,000 tumor-normal exome pairs...
Genome-wide somatic mutation profiles of tumours can now be assessed efficiently and promise to move...
Many forms of cancer have multiple subtypes with different causes and clinical outcomes. Somatic tum...
<div><p>The stratification of cancer into subtypes that are significantly associated with clinical o...
The stratification of cancer into subtypes that are significantly associated with clinical outcomes ...
Large-scale cancer genomics projects are providing a wealth of somatic mutation data from a large nu...
A major goal of cancer sequencing projects is to identify genetic alterations that determine clinica...
BACKGROUND: Cancers are complex diseases with heterogeneous genetic causes and clinical outcomes. It...
Genome-wide measurements of genomic state offer unprecedented opportunities for biological discovery...
A major challenge for distinguishing cancer-causing driver mutations from inconsequential passenger ...
A central goal in cancer genomics is to identify the somatic alterations that underpin tumor initiat...
Next-generation sequencing technologies allow to measure somatic mutations in a large number of pati...
The post-genomic era has resulted in the accumulation of high-throughput cancer data from a vast arr...
Disease progression in cancer can vary substantially between patients. Yet, patients often receive t...
<div><p>Development of high-throughput monitoring technologies enables interrogation of cancer sampl...
The Cancer Genome Atlas (TCGA) cancer genomics dataset includes over 10,000 tumor-normal exome pairs...